Inventor · disambiguated record
Scott E. Zook
Also filed as: ZOOK SCOTT E · ZOOK Scott
12 granted patents·4 pending applications·84 citations·filing 1996–2020
89Inventor score
Top patents by PatentIndex Score
16 records- 0195US10065952B2Valbenazine salts and polymorphs thereofNEUROCRINE BIOSCIENCES INC·Filed 2016·Granted Sep 4, 2018·30 cites·17 claims
- 0290US10851103B2Valbenazine salts and polymorphs thereofNEUROCRINE BIOSCIENCES INC·Filed 2020·Granted Dec 1, 2020·2 cites·27 claims
- 0390US10851104B2Valbenazine salts and polymorphs thereofNEUROCRINE BIOSCIENCES INC·Filed 2020·Granted Dec 1, 2020·2 cites·29 claims
- 0490US10844058B2Valbenazine salts and polymorphs thereofNEUROCRINE BIOSCIENCES INC·Filed 2020·Granted Nov 24, 2020·2 cites·27 claims
- 0579US6500948B1Metalloproteinase inhibitors-compositions, uses preparation and intermediates thereofAGOURON PHARMA·Filed 2000·Granted Dec 31, 2002·9 cites·35 claims
- 0671US6849732B2Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses, and methods and intermediates useful for their preparationAGOURON PHARMA·Filed 2002·Granted Feb 1, 2005·4 cites·15 claims
- 0771US6153757AMetalloproteinase inhibitors and intermediates useful for their preparationAGOURON PHARMA·Filed 1996·Granted Nov 28, 2000·29 cites·4 claims
- 0870US6903106B2Polymorph of N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-α]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related theretoNEUROCRINE BIOSCIENCES INC·Filed 2003·Granted Jun 7, 2005·6 cites·42 claims
- 0959US2008132700A1Hydrate of n-methyl-n-(3-phenyl)acetamide and processes and methods related theretoNEUROCRINE BIOSCIENCES INC·Filed 2007·Application pending·0 cites
- 1054US7459458B2Polymorph of N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-α]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related theretoNEUROCRINE BIOSCIENCES INC·Filed 2004·Granted Dec 2, 2008·0 cites·2 claims
- 1154US7304069B2Hydrate of N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5α]-pyrimidin-7-yl}phenyl)acetamide and processes and methods related theretoNEUROCRINE BIOSCIENCES INC·Filed 2005·Granted Dec 4, 2007·0 cites·10 claims
- 1250US6472534B2Methods for the preparation of intermediates in the synthesis of HIV-protease inhibitorsAGOURON PHARMA·Filed 2001·Granted Oct 29, 2002·0 cites·20 claims
- 1349US2003023092A1Methods for the preparation of intermediates in the synthesis of HIV-protease inhibitorsFiled 2002·Application pending·0 cites
- 1448US6403799B1Methods for the preparation of intermediates in the synthesis of HIV-protease inhibitorsAGOURON PHARMA·Filed 2000·Granted Jun 11, 2002·0 cites·16 claims
- 1541US2006094763A1Polymorphic forms of 6-[2-(methylcarbomoyl) phenyl sulfanyl]-3-E-[2-(pyridin-2-yl)ethenyl]indazoleAGOURON PHARMA·Filed 2005·Application pending·0 cites
- 1640US2005267158A1Polymorphic and amorphous forms of 2,5-dimethyl-2H-pyrazole-3-carboxylic acid {2-fluoro-5-[3-((E)-2 pyridin-2-YL-vinyl)-1H-indazol-6-ylamino]-phenyl}-amideAGOURON PHARMA·Filed 2005·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →